We’re loaded this week!
Do you know what the PDRP is? If not, you can’t know how it’s changing pharmaceutical selling.
Alpharma gets some pain relief.
Disappointing delay for Novartis on the new diabetes treatment Galvus.
While we’re at it, disappointment at Novo on brain hemorrhage treatment using NovoSeven.
Ed Silverman addresses the female sexual dysfunction thing.
Here come the counter-detailers!
Beta-blockers: move to the back of the line!
AstraZeneca makes a big donation toward cancer care.
Add green tea and COX-2 to slow prostate cancer?
Does cancer resist treatment through cancer stem cells?
Got milk? Will it help you fight cancer?